Pharmaceutical Residues in Northern European Environments: Consequences and Perspectives

  • R. Kallenborn
  • J. Fick
  • R. Lindberg
  • M. Moe
  • K. M. Nielsen
  • M. Tysklind
  • T. Vasskog


Particulate Organic Carbon Pharmaceutical Substance Pharmaceutical Residue Middle Latitude Region Northern Environment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alonso, A, Sancjhez P, Martinez JL (2001) Environmental selection of antibiotic resistance genes. Environ Microbiol 3:1–9CrossRefGoogle Scholar
  2. AMAP (2004) AMAP Assessment 2002: Persistent organic pollutants in the Arctic. Arctic Monitoring and Assessment Programme (AMAP), Oslo, NorwayGoogle Scholar
  3. Apoteket (2006) Pharmaceuticals and the environment. ISBN 91-85574-55-4, 142 ppGoogle Scholar
  4. Bano N, Hollibaugh T (2002) Phylogenetic composition of bacterioplankton assemblages from the Arctic Ocean. Appl Environ Microbiol 68:505–518CrossRefGoogle Scholar
  5. Burkow IC, Kallenborn R (2000) Sources and transport of persistent pollutants to the Arctic. Toxicol Letters 112–113:87–92CrossRefGoogle Scholar
  6. Berg T, Kallenborn R, Manø S (2004) Temporal trends in atmospheric heavy metal and organochlorine concentrations at Zeppelin, Svalbard. Arctic Antarctic Alpine Research 36:283–290Google Scholar
  7. Brinkmeyer R, Knittel K, J¨rgens J, Weyland H, Amann R, Helmke E (2003) Diversity and structure of bacterial communities in Arctic versus Antarctic pack ice. Appl Environ Microbiol 69: 6610–6619CrossRefGoogle Scholar
  8. Brusetti L, Glad T, Borin S, Myren P, Rizzi A, Johnsen P, Carter P, Daffonchio D, Nielsen KM (2008) Low prevalence of blaTEM genes in Arctic and agricultural soil and rhizosphere. Microb Ecol Health Dis 20:27–36Google Scholar
  9. Cardoza LA, Knapp CW, Larive CK, Belden JB, Lydy M, Graham DW (2005) Factors affecting the fate of ciprofloxacin in aquatic field systems. Wat Air Soil Poll 161:383–398CrossRefGoogle Scholar
  10. DANMAP (2006) Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. ISSN 1600-2032, 101 ppGoogle Scholar
  11. Engelsen O, Brustad M, Aksnes L, Lund E (2005) Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol 81:1287–1290CrossRefGoogle Scholar
  12. Esiobu N, Armenta L, Ike J (2002) Antibiotic resistance in soil and water environments. Int J Environ Health Res 12:133–144CrossRefGoogle Scholar
  13. Evenseth A, Christensen G, Kallenborn R (2005) Selected chlorobornanes, polychlorinated naphthalenes and brominated flame retardants in Bjørnøya (Bear Island) freshwater biota. Environ Poll 136:419–430CrossRefGoogle Scholar
  14. Fick J, Lindberg RH, Tysklind M, Haemig PD, Waldenstrom J (2007) Antiviral Oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by Influenza A Virus. PLoS ONE 2(10):e986 (doi:10.1371/journal.pone.0000986)Google Scholar
  15. Fong PP (1998) Zebra mussel spawning is induced in low concentrations of putative serotonin reuptake inhibitors. Biol Bull 194:143–149CrossRefGoogle Scholar
  16. Halling-Sørensen B, Nielsen SN, Lanzky PF, Ingerslev F, L¨tzhøft HCH, Jørgensen SE (1998) Occurrence, fate, and effects of pharmaceutical substances in the environment – a review. Chemosphere 36:357–393CrossRefGoogle Scholar
  17. Helland T, Laengin A, Bolek R, Bergheim M, Kallenborn R, K¨mmerer K (2008) Temperature dependent biodegradation tests of penicillin-G applying the Zahn-Wellens test under controlled laboratory conditions. Chemosphere (in preparation)Google Scholar
  18. Henriques I, Moura A, Alves A, Saavedra MJ, Correia A. (2006) Analyzing diversity among beta-lactamase encoding genes in aquatic environments. FEMS Microbiol Ecol 56:418–429CrossRefGoogle Scholar
  19. Hirsch R, Ternes T, Haberer K, Kratz KL (1999) Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225:109–118CrossRefGoogle Scholar
  20. Ho TS, Vasskog T, Anderssen T, Jensen E, Rasmussen KE, Pedersen-Bjergaard S (2007) 25000-fold preconcentration in a single step with liquid-phase micro-extraction. Anal Chim Acta 592:1–8CrossRefGoogle Scholar
  21. K¨mmerer K (2004) Resistance in the environment. J Antimicrob Chemoth 54:311–320CrossRefGoogle Scholar
  22. Lindberg RH, Wennberg P, Johansson MI, Tysklind M, Andersson BAV (2005) Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants. Environ Sci Technol 39:3421–3429CrossRefGoogle Scholar
  23. Lindqvist N, Tuhkanen T, Kronberg L (2005) Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res 39:2219–2228CrossRefGoogle Scholar
  24. Llorens Abando L, Rohner-Thielen E (2007) Different organic farming patterns within EU-25. Stat in Focus 69:1–7Google Scholar
  25. Maki T, Hasegawa H, Kitami H, Fumoto K, Munekage Y, Ueda K (2006) Bacterial degradation of antibiotic residues in marine fish farm sediments of Uranouchi Bay and phylogenetic analysis of antibiotic- degrading bacteria using 16S rDNA sequences. Fisheries Sci 72:811–820CrossRefGoogle Scholar
  26. NORM/NORM-VET (2006) Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Tromsø / Oslo 2007. ISSN 1502-2307Google Scholar
  27. Orbaek JB, Kallenborn R, Tombre I, Hegseth EN, Falk-Petersen S, Hoel AH (eds) (2007) Arctic alpine ecosystems and people in a changing environment. Springer-Verlag, BerlinGoogle Scholar
  28. Ravenschlag K, Sahm K, Amann R (2001) Quantitative molecular analysis of the microbial community in marine arctic sediments (Svalbard). Appl Environ Microbiol 67:387–395CrossRefGoogle Scholar
  29. SFT (2007a) Occurrence of selected pharmaceuticals in wastewater effluents from hospitals (Ullevål and Rikshospitalet) and VEAS wastewater treatment works. Report TA-2246/2007, 37 ppGoogle Scholar
  30. SFT (2007b) Human and veterinary pharmaceuticals, narcotics, and personal care products in the environment. Report 2325/2007, 106 ppGoogle Scholar
  31. Su Y, Hung H, Blanchard P, Patton GW, Kallenborn R, Konoplev A, Fellin P, Li H, Geen C, Stern G, Rosenberg B, Barrie L (2006) Spatial and seasonal variations of hexachlorocyclohexanes (HCHs) and hexachlorobenzene (HCB) in the arctic atmosphere. Environ Sci Technol 40:6601–6607Google Scholar
  32. SWEDRES (2006) A Report on Swedish antibiotic utilisation and resistance in human medicine. Swedish Institute for Infectious Disease Control, Solna, Sweden, 42 ppGoogle Scholar
  33. Vasskog T, Berger U, Samuelsen PJ, Kallenborn R, Jensen E (2006) Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway. J Chromatogr A 1115:187–195CrossRefGoogle Scholar
  34. Vasskog T, Anderssen T, Pedersen-Bjergaard S, Kallenborn R, Jensen E (2008) Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. J Chromatogr A (submitted)Google Scholar
  35. Vieno N, Tuhkanen T, Kronberg L (2006) Analysis of neutral and basic pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase extraction and liquid chromatography – tandem mass spectrometry detection. J Chromatogr A 1134:101–111CrossRefGoogle Scholar
  36. Weigel S (2003) Occurrence, distribution and fate of pharmaceuticals and further polar contaminants in the marine environment. PhD Thesis, University of Hamburg (Germany), Institute of Organic Chemistry, 145 ppGoogle Scholar
  37. Weigel S, Berger U, Jensen E, Kallenborn R, Thoresen H, H¨hnerfuss H (2004) Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 56:583–592CrossRefGoogle Scholar
  38. Wennmalm A, Gunnarsson B (2005) Public health care management of water pollution with pharmaceuticals: environmental classification and analysis of pharmaceutical residues in sewage water. Drug Info J 39:291–297Google Scholar
  39. Woldegiorgis AGJ, Remberger R, Kaj L, Brorstöm-Lundén E, Dye C, Schlabach M (2007) Results from the Swedish screening 2006, Sub report 4: Pharmaceuticals. Stockholm, IVL Swedish Environmental Research Institute Ltd, 68 ppGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • R. Kallenborn
    • 1
  • J. Fick
    • 2
  • R. Lindberg
    • 2
  • M. Moe
    • 3
  • K. M. Nielsen
    • 4
  • M. Tysklind
    • 2
  • T. Vasskog
    • 4
  1. 1.University Centre in Svalbard (UNIS)Norway
  2. 2.Environmental ChemistryUmeå UniversitySweden
  3. 3.Polar Environmental CentreNorwegian Institute for Air Research (NILU)Norway
  4. 4.Department of PharmacyTromsø UniversityNorway

Personalised recommendations